European Commission President Ursula Von der Leyen announced Tuesday the European Union has reached a deal with U.S. biotech company Moderna for 160 million doses of its coronavirus vaccine candidate. Last week, Moderna said interim data from late-stage clinical trials of its experimental vaccine...
Full ArticleEU Near Deal with Moderna on Coronavirus Vaccine
WorldNews
0 shares
1 views
You might like
Related news coverage
US stocks end down to close a historic November rally
Proactive Investors
4:05 pm: US equities down as investors book profits US stocks closed down sharply as investors booked profits following a historic..
-
US stocks seeing red at mid-session; Dow Jones looks for best monthly gain since 1987
Proactive Investors
-
US benchmarks open mixed on Monday but remain poised to post historic gains in November
Proactive Investors
-
US markets look set for subdued return to a full day's trading after Thanksgiving and Black Friday
Proactive Investors
-
Germany prepares to roll out vaccines soon, as cases hit 1 million
Mid-Day
Advertisement
More coverage
Lowering The Bar On Success: Megan McArdle On Drug Development – OpEd
Eurasia Review
Washington Post columnist Megan McArdle was anxious to tell readers that drug development in the pandemic has been a great..
-
EU says first virus vaccinations possible by Christmas
SeattlePI.com
-
EU seals 6th vaccine deal, secures 160 million Moderna shots
SeattlePI.com
-
Coronavirus digest: EU agrees vaccine deal with Moderna
Deutsche Welle
-
Pfizer, Moderna COVID-19 vaccine candidates may get EU approval in December
Proactive Investors